Dysregulation of Synaptic Plasticity Precedes Appearance of Morphological Defects in a Pten Conditional Knockout Mouse Model of Autism

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2013 Mar 15

PMID 23487788

Citations 67

Authors

Koichi Takeuchi

Michael J Gertner

Jing Zhou

Luis F Parada

Michael V L Bennett

R Suzanne Zukin

Affiliations

Soon will be listed here.

Abstract

The phosphoinositide signaling system is a crucial regulator of neural development, cell survival, and plasticity. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) negatively regulates phosphatidylinositol 3-kinase signaling and downstream targets. Nse-Cre Pten conditional knockout mice, in which Pten is ablated in granule cells of the dentate gyrus and pyramidal neurons of the hippocampal CA3, but not CA1, recapitulate many of the symptoms of humans with inactivating PTEN mutations, including progressive hypertrophy of the dentate gyrus and deficits in hippocampus-based social and cognitive behaviors. However, the impact of Pten loss on activity-dependent synaptic plasticity in this clinically relevant mouse model of Pten inactivation remains unclear. Here, we show that two phosphatidylinositol 3-kinase- and protein synthesis-dependent forms of synaptic plasticity, theta burst-induced long-term potentiation and metabotropic glutamate receptor (mGluR)-dependent long-term depression, are dysregulated at medial perforant path-to-dentate gyrus synapses of young Nse-Cre Pten conditional knockout mice before the onset of visible morphological abnormalities. In contrast, long-term potentiation and mGluR-dependent long-term depression are normal at CA3-CA1 pyramidal cell synapses at this age. Our results reveal that deletion of Pten in dentate granule cells dysregulates synaptic plasticity, a defect that may underlie abnormal social and cognitive behaviors observed in humans with Pten inactivating mutations and potentially other autism spectrum disorders.

Citing Articles

Genetically encoded biosensor for fluorescence lifetime imaging of PTEN dynamics in the intact brain.

Kagan T, Gabay M, Meenakshisundaram A, Levi Y, Eid S, Malchenko N Nat Methods. 2025; .

PMID: 39979596 DOI: 10.1038/s41592-025-02610-9.

Mutation in the mitochondrial chaperone TRAP1 leads to autism with more severe symptoms in males.

Rydzanicz M, Kuzniewska B, Magnowska M, Wojtowicz T, Stawikowska A, Hojka A EMBO Mol Med. 2024; 16(11):2976-3004.

PMID: 39333440 PMC: 11554806. DOI: 10.1038/s44321-024-00147-6.

Dentate Gyrus Morphogenesis is Regulated by an Autism Risk Gene Trio Function in Granule Cells.

Sun M, Xue W, Meng H, Sun X, Lu T, Yue W Neurosci Bull. 2024; 41(1):1-15.

PMID: 38907786 PMC: 11748712. DOI: 10.1007/s12264-024-01241-y.

Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on hippocampal long-term potentiation at perforant pathway-dentate gyrus synapses in prenatal valproic acid-induced rat model of autism.

Gholipour P, Ebrahimi Z, Mohammadkhani R, Ghahremani R, Salehi I, Sarihi A Sci Rep. 2024; 14(1):13168.

PMID: 38849397 PMC: 11161498. DOI: 10.1038/s41598-024-63728-y.

Effect of intrahippocampal microinjection of VU0155041, a positive allosteric modulator of mGluR4, on long term potentiation in a valproic acid-induced autistic male rat model.

Ebrahimi Z, Gholipour P, Mohammadkhani R, Ghahremani R, Sarihi A, Komaki A IBRO Neurosci Rep. 2024; 16:629-634.

PMID: 38832089 PMC: 11144792. DOI: 10.1016/j.ibneur.2024.05.005.

References

Malenka R, Bear M . LTP and LTD: an embarrassment of riches. Neuron. 2004; 44(1):5-21. DOI: 10.1016/j.neuron.2004.09.012. View

Klauck S . Genetics of autism spectrum disorder. Eur J Hum Genet. 2006; 14(6):714-20. DOI: 10.1038/sj.ejhg.5201610. View

Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang S . PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997; 275(5308):1943-7. DOI: 10.1126/science.275.5308.1943. View

Opazo P, Watabe A, Grant S, ODell T . Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms. J Neurosci. 2003; 23(9):3679-88. PMC: 6742185. View

Page D, Kuti O, Prestia C, Sur M . Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior. Proc Natl Acad Sci U S A. 2009; 106(6):1989-94. PMC: 2644151. DOI: 10.1073/pnas.0804428106. View

Bourgeron T . A synaptic trek to autism. Curr Opin Neurobiol. 2009; 19(2):231-4. DOI: 10.1016/j.conb.2009.06.003. View

Zhou J, Parada L . PTEN signaling in autism spectrum disorders. Curr Opin Neurobiol. 2012; 22(5):873-9. DOI: 10.1016/j.conb.2012.05.004. View

Krueppel R, Remy S, Beck H . Dendritic integration in hippocampal dentate granule cells. Neuron. 2011; 71(3):512-28. DOI: 10.1016/j.neuron.2011.05.043. View

Naie K, Manahan-Vaughan D . Investigations of the protein synthesis dependency of mGluR-induced long-term depression in the dentate gyrus of freely moving rats. Neuropharmacology. 2005; 49 Suppl 1:35-44. DOI: 10.1016/j.neuropharm.2005.06.001. View

10.

Nguyen P, Woo N . Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases. Prog Neurobiol. 2004; 71(6):401-37. DOI: 10.1016/j.pneurobio.2003.12.003. View

11.

Kwon C, Zhou J, Li Y, Kim K, Hensley L, Baker S . Neuron-specific enolase-cre mouse line with cre activity in specific neuronal populations. Genesis. 2006; 44(3):130-5. DOI: 10.1002/gene.20197. View

12.

Soriano P . Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet. 1999; 21(1):70-1. DOI: 10.1038/5007. View

13.

Wallace M, Burette A, Weinberg R, Philpot B . Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects. Neuron. 2012; 74(5):793-800. PMC: 3372864. DOI: 10.1016/j.neuron.2012.03.036. View

14.

Auerbach B, Osterweil E, Bear M . Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature. 2011; 480(7375):63-8. PMC: 3228874. DOI: 10.1038/nature10658. View

15.

Zhou J, Blundell J, Ogawa S, Kwon C, Zhang W, Sinton C . Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci. 2009; 29(6):1773-83. PMC: 3904448. DOI: 10.1523/JNEUROSCI.5685-08.2009. View

16.

Laplante M, Sabatini D . mTOR signaling in growth control and disease. Cell. 2012; 149(2):274-93. PMC: 3331679. DOI: 10.1016/j.cell.2012.03.017. View

17.

Goffin A, Hoefsloot L, Bosgoed E, Swillen A, Fryns J . PTEN mutation in a family with Cowden syndrome and autism. Am J Med Genet. 2001; 105(6):521-4. DOI: 10.1002/ajmg.1477. View

18.

McBride K, Varga E, Pastore M, Prior T, Manickam K, Atkin J . Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res. 2010; 3(3):137-41. DOI: 10.1002/aur.132. View

19.

Sharma A, Hoeffer C, Takayasu Y, Miyawaki T, McBride S, Klann E . Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci. 2010; 30(2):694-702. PMC: 3665010. DOI: 10.1523/JNEUROSCI.3696-09.2010. View

20.

Wang Y, Cheng A, Mattson M . The PTEN phosphatase is essential for long-term depression of hippocampal synapses. Neuromolecular Med. 2006; 8(3):329-36. DOI: 10.1385/NMM:8:3:329. View